文献速递哮喘

轻中度哮喘停用吸入糖皮质激素后失控与经典粒细胞活化无关

Corticosteroid Withdrawal-Induced Loss of Control in Mild to Moderate Asthma Is Independent of Classic Granulocyte Activation.
PubMed 文献 · Chest · 2019-10-14

失控期痰嗜酸性粒细胞增多,但多数炎症与氧化应激指标及嗜酸性粒细胞和中性粒细胞活化标志物在三阶段间无差异;游离嗜酸性颗粒和瓜氨酸化组蛋白H3增高,基线血嗜酸性粒细胞及血浆非对称二甲基精氨酸变化与FEV1占预计值百分比下降相关(rs=0.46,P=.03)。结论提示ICS中断后的临床效应与经典粒细胞炎症活化无关。

要点

  • 轻中度哮喘ICS撤药后失控以痰嗜酸性粒细胞增多为特征,但经典粒细胞活化标志物无变化。
  • 游离嗜酸性颗粒和瓜氨酸化组蛋白H3增高提示嗜酸性粒细胞溶解及可能的外诱捕网形成。
  • 基线血嗜酸性粒细胞和血浆ADMA变化与ICS撤药后FEV1占预计值百分比下降相关(rs=0.46,P=.03)。

核心结论

  • 轻中度哮喘中断ICS治疗后的临床效应与嗜酸性粒细胞和中性粒细胞的经典炎症活化无关,可能反映失控和急性发作的其他通路。

研究设计与样本

  • 在基线、失控期和恢复后三阶段采集呼出气冷凝液、血浆和痰液,评估免疫、炎症、氧化应激参数及嗜酸/中性粒细胞活性标志物。

主要发现

  • 哮喘失控期痰嗜酸性粒细胞增多,但多数炎症和氧化应激反应在三阶段间无差异。
  • 活化的嗜酸性粒细胞标志物(嗜酸性粒细胞阳离子蛋白和溴酪氨酸)及中性粒细胞标志物(髓过氧化物酶和氯酪氨酸)在三阶段间无差异。
  • 游离嗜酸性颗粒和瓜氨酸化组蛋白H3增高,提示嗜酸性粒细胞溶解及可能的嗜酸性粒细胞胞外诱捕网形成。
  • 基线血嗜酸性粒细胞及血浆非对称二甲基精氨酸变化与ICS撤药后FEV1占预计值百分比下降相关(均rs=0.46;P=.03)。

临床怎么用

  • 轻中度哮喘ICS撤药后失控的评估不应仅依赖经典粒细胞活化标志物,需关注嗜酸性粒细胞溶解相关标志物及基线血嗜酸性粒细胞。
  • 基线血嗜酸性粒细胞和血浆ADMA变化可能与ICS撤药后肺功能下降相关,或有助于识别高风险患者。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Loss of asthma control and asthma exacerbations are associated with increased sputum eosinophil counts. However, whether eosinophils, or the also present neutrophils, actively contribute to the accompanying inflammation has not been extensively investigated. METHODS: Twenty-three patients with mild to moderate asthma were included in a standardized prospective inhaled corticosteroid (ICS) withdrawal study; 22 of the patients experienced loss of asthma control. The study assessed various immune, inflammatory, and oxidative stress parameters, as well as markers of eosinophil and neutrophil activity, in exhaled breath condensate, plasma, and sputum collected at three phases (baseline, during loss of control, and following recovery). RESULTS: Loss of asthma control was characterized by increased sputum eosinophils, whereas no differences were detected between the three phases for most inflammatory and oxidative stress responses. There were also no differences detected for markers of activated eosinophils (eosinophil cationic protein and bromotyrosine) and neutrophils (myeloperoxidase and chlorotyrosine). However, free eosinophilic granules and citrullinated histone H3, suggestive of eosinophil cytolysis and potentially eosinophil extracellular trap formation, were enhanced. Baseline blood eosinophils and changes in asymmetric dimethylarginine (an inhibitor of nitric oxide synthase) in plasma were found to correlate with the decrease in FEV1 percent predicted upon ICS withdrawal (both, rs = 0.46; P = .03). CONCLUSIONS: The clinical effect in mild to moderate asthma upon interruption of ICS therapy is not related to the classic inflammatory activation of eosinophils and neutrophils. It may, however, reflect another pathway underlying the onset of loss of disease control and asthma exacerbations. TRIAL REGISTRY: The Netherlands Trial Register; No.: NTR3316; URL: trialregister.nl/trial/3172.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. de Groot LES, van de Pol MA, Fens N, et al. Corticosteroid Withdrawal-Induced Loss of Control in Mild to Moderate Asthma Is Independent of Classic Granulocyte Activation. Chest. 2019. PMID: 31622588. doi:10.1016/j.chest.2019.09.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。